These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 19723379

  • 21. Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease.
    Lawn SD, Edwards DJ, Kranzer K, Vogt M, Bekker LG, Wood R.
    AIDS; 2009 Sep 10; 23(14):1875-80. PubMed ID: 20108382
    [Abstract] [Full Text] [Related]

  • 22. Real-world diagnostic accuracy of lipoarabinomannan in three non-sputum biospecimens for pulmonary tuberculosis disease.
    Drain PK, Niu X, Shapiro AE, Magcaba ZP, Ngcobo Z, Ngwane MW, Thomas KK, Dalmat RR, Morton JF, Budiawan E, Pinter A, Cantera J, Anderson C, Buchmann R, Wilson D, Grant B, Prove-TB Study team.
    EBioMedicine; 2024 Oct 10; 108():105353. PubMed ID: 39332390
    [Abstract] [Full Text] [Related]

  • 23. [Comparison of the performances of MTD Gene-Probe® test, BACTEC 960™ system and Löwenstein-Jensen culture methods in the diagnosis of smear-negative tuberculosis cases].
    Kunduracıoğlu A, Karasu I, Biçmen C, Ozsöz A, Erbaycu AE.
    Mikrobiyol Bul; 2013 Jul 10; 47(3):417-31. PubMed ID: 23971920
    [Abstract] [Full Text] [Related]

  • 24. Rapid Urine LAM Testing Improves Diagnosis of Expectorated Smear-Negative Pulmonary Tuberculosis in an HIV-endemic Region.
    Drain PK, Gounder L, Sahid F, Moosa MY.
    Sci Rep; 2016 Feb 11; 6():19992. PubMed ID: 26865526
    [Abstract] [Full Text] [Related]

  • 25. Diagnostic accuracy of a novel tuberculosis point-of-care urine lipoarabinomannan assay for people living with HIV: A meta-analysis of individual in- and outpatient data.
    Broger T, Nicol MP, Székely R, Bjerrum S, Sossen B, Schutz C, Opintan JA, Johansen IS, Mitarai S, Chikamatsu K, Kerkhoff AD, Macé A, Ongarello S, Meintjes G, Denkinger CM, Schumacher SG.
    PLoS Med; 2020 May 11; 17(5):e1003113. PubMed ID: 32357197
    [Abstract] [Full Text] [Related]

  • 26. Urinary lipoarabinomannan in individuals with sputum-negative pulmonary tuberculosis.
    Ajantha P, Puri MM, Tayal D, Khalid U.
    Indian J Med Res; 2024 Feb 01; 159(2):206-212. PubMed ID: 38577859
    [Abstract] [Full Text] [Related]

  • 27. The utility of point-of-care urinary lipoarabinomannan testing for the diagnosis of tuberculosis in critically ill patients: a prospective observational study.
    de Vasconcellos K, Ramjathan P, Singh D.
    BMC Infect Dis; 2021 Mar 19; 21(1):281. PubMed ID: 33740905
    [Abstract] [Full Text] [Related]

  • 28. Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a High HIV prevalence setting.
    Shah M, Variava E, Holmes CB, Coppin A, Golub JE, McCallum J, Wong M, Luke B, Martin DJ, Chaisson RE, Dorman SE, Martinson NA.
    J Acquir Immune Defic Syndr; 2009 Oct 01; 52(2):145-51. PubMed ID: 19692904
    [Abstract] [Full Text] [Related]

  • 29. Diagnostic evaluation of urinary lipoarabinomannan at an Ethiopian tuberculosis centre.
    Tessema TA, Hamasur B, Bjun G, Svenson S, Bjorvatn B.
    Scand J Infect Dis; 2001 Oct 01; 33(4):279-84. PubMed ID: 11345220
    [Abstract] [Full Text] [Related]

  • 30. A Novel Sensitive Immunoassay Targeting the 5-Methylthio-d-Xylofuranose-Lipoarabinomannan Epitope Meets the WHO's Performance Target for Tuberculosis Diagnosis.
    Sigal GB, Pinter A, Lowary TL, Kawasaki M, Li A, Mathew A, Tsionsky M, Zheng RB, Plisova T, Shen K, Katsuragi K, Choudhary A, Honnen WJ, Nahid P, Denkinger CM, Broger T.
    J Clin Microbiol; 2018 Dec 01; 56(12):. PubMed ID: 30257899
    [Abstract] [Full Text] [Related]

  • 31. Urine lipoarabinomannan to monitor antituberculosis therapy response and predict mortality in an HIV-endemic region: a prospective cohort study.
    Drain PK, Gounder L, Grobler A, Sahid F, Bassett IV, Moosa MY.
    BMJ Open; 2015 Apr 15; 5(4):e006833. PubMed ID: 25877271
    [Abstract] [Full Text] [Related]

  • 32. Performance of Tuberculosis Molecular Bacterial Load Assay Compared to Alere TB-LAM in Urine of Pulmonary Tuberculosis Patients with HIV Co-Infections.
    Mapamba DA, Sauli E, Lalashowi J, Buza J, John J, Mwaisango Z, Tarmo P, Sabi I, Rachow A, Ntinginya NE, Mtafya B.
    Int J Mol Sci; 2023 Feb 13; 24(4):. PubMed ID: 36835127
    [Abstract] [Full Text] [Related]

  • 33. Point-of-care urine lipoarabinomannan antigen detection for diagnosis of tuberculosis in children.
    Gautam H, Singla M, Jain R, Lodha R, Kabra SK, Singh UB.
    Int J Tuberc Lung Dis; 2019 Jun 01; 23(6):714-719. PubMed ID: 31315704
    [Abstract] [Full Text] [Related]

  • 34. Utility of urine lipoarabinomannan (LAM) in diagnosing tuberculosis and predicting mortality with and without HIV: prospective TB cohort from the Thailand Big City TB Research Network.
    Suwanpimolkul G, Kawkitinarong K, Manosuthi W, Sophonphan J, Gatechompol S, Ohata PJ, Ubolyam S, Iampornsin T, Katerattanakul P, Avihingsanon A, Ruxrungtham K.
    Int J Infect Dis; 2017 Jun 01; 59():96-102. PubMed ID: 28457751
    [Abstract] [Full Text] [Related]

  • 35. Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples.
    Dheda K, Davids V, Lenders L, Roberts T, Meldau R, Ling D, Brunet L, van Zyl Smit R, Peter J, Green C, Badri M, Sechi L, Sharma S, Hoelscher M, Dawson R, Whitelaw A, Blackburn J, Pai M, Zumla A.
    PLoS One; 2010 Mar 24; 5(3):e9848. PubMed ID: 20352098
    [Abstract] [Full Text] [Related]

  • 36. Antigen detection as a point-of-care test for TB: the case of lipoarabinomannan.
    Swaminathan S, Rekha VV.
    Future Microbiol; 2012 May 24; 7(5):559-64. PubMed ID: 22568711
    [Abstract] [Full Text] [Related]

  • 37. Lipoarabinomannan in urine during tuberculosis treatment: association with host and pathogen factors and mycobacteriuria.
    Wood R, Racow K, Bekker LG, Middelkoop K, Vogt M, Kreiswirth BN, Lawn SD.
    BMC Infect Dis; 2012 Feb 27; 12():47. PubMed ID: 22369353
    [Abstract] [Full Text] [Related]

  • 38. Accuracy of the tuberculosis point-of-care Alere determine lipoarabinomannan antigen diagnostic test using α-mannosidase treated and untreated urine in a cohort of people living with HIV in Guatemala.
    García JI, Meléndez J, Álvarez R, Mejía-Chew C, Kelley HV, Sidiki S, Castillo A, Mazariegos C, López-Téllez C, Forno D, Ayala N, Balada-Llasat JM, Mejía-Villatoro CR, Wang SH, Torrelles JB, Ikeda J.
    AIDS Res Ther; 2020 Oct 19; 17(1):62. PubMed ID: 33076996
    [Abstract] [Full Text] [Related]

  • 39. Diagnostic accuracy of a rapid urine lipoarabinomannan test for tuberculosis in HIV-infected adults.
    Nakiyingi L, Moodley VM, Manabe YC, Nicol MP, Holshouser M, Armstrong DT, Zemanay W, Sikhondze W, Mbabazi O, Nonyane BA, Shah M, Joloba ML, Alland D, Ellner JJ, Dorman SE.
    J Acquir Immune Defic Syndr; 2014 Jul 01; 66(3):270-9. PubMed ID: 24675585
    [Abstract] [Full Text] [Related]

  • 40. Urinary LAM grade, culture positivity, and mortality among HIV-infected South African out-patients.
    Kubiak RW, Herbeck JT, Coleman SM, Ross D, Freedberg K, Bassett IV, Drain PK.
    Int J Tuberc Lung Dis; 2018 Nov 01; 22(11):1366-1373. PubMed ID: 30355418
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.